General contact

Main switchboard
Switzerland

+41 61 324 11 11
+41 61 324 80 01
Monday - Friday,
8:30 a.m. - 5:00 p.m. GMT+1

US switchboard

+1 862 778 21 00
Monday - Friday,
8:30 a.m. - 5:00 p.m. EST

Media

Global Media Relations
Eric Althoff
Basel, Switzerland

+41 61 324 7999

Investors

Investor Relations
Switzerland

Monday - Friday,
8:30 a.m. - 5:30 p.m. GMT+1
(Central European Time)

Reporting side effects

Report a suspected side effect (also known as an adverse event) related to a Novartis Pharmaceutical drug or a Novartis Vaccine.

Reporting side effects

pane 4 content

Annual General Meeting

Date: Tuesday, 25 February 2014, 10:00 CET
Place: St. Jakobshalle, Basel, Switzerland

Watch the webcast


Transportation

Shareholders are requested to use public transport since parking facilities at the St. Jakobshalle are limited.

From central Basel, take tram 14 (direction Pratteln) to the stop St. Jakob.

Directions

Get directions:

Stock chart
Q3 Results 2013

On Thursday, April 24, Novartis will announce its results for the first quarter of 2014